Exon skipping and gene transfer restore dystrophin expression in human induced pluripotent stem cells-cardiomyocytes harboring DMD mutations.
about
Young at Heart: Pioneering Approaches to Model Nonischaemic Cardiomyopathy with Induced Pluripotent Stem CellsNew approaches to the treatment of orphan genetic disorders: Mitigating molecular pathologies using chemicalsEnhanced Reprogramming Efficiency and Kinetics of Induced Pluripotent Stem Cells Derived from Human Duchenne Muscular DystrophyDystrophin-deficient cardiomyocytes derived from human urine: new biologic reagents for drug discovery.Generation of induced pluripotent stem cells from muscular dystrophy patients: efficient integration-free reprogramming of urine derived cells.Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy.Prospects for In Vitro Myofilament Maturation in Stem Cell-Derived Cardiac Myocytes.X-Linked Dilated Cardiomyopathy: A Cardiospecific Phenotype of Dystrophinopathy.Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.Treatment of dystrophin cardiomyopathies.Concise Review: Patient-Derived Stem Cell Research for Monogenic Disorders.Gene therapy in monogenic congenital myopathies.Induced pluripotent stem cells: at the heart of cardiovascular precision medicine.Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy.Nicorandil, a Nitric Oxide Donor and ATP-Sensitive Potassium Channel Opener, Protects Against Dystrophin-Deficient Cardiomyopathy.MRC Centre Neuromuscular Biobank (Newcastle and London): Supporting and facilitating rare and neuromuscular disease research worldwide.Direct reprogramming of urine-derived cells with inducible MyoD for modeling human muscle disease.Dystrophin Cardiomyopathies: Clinical Management, Molecular Pathogenesis and Evolution towards Precision Medicine
P2860
Q26750663-26D35A5C-F10E-45A3-ACD9-D9F8FCE66C97Q26801582-6B7326E7-8AEE-41B5-9BE4-CD4EEB1CF01BQ28550776-41024C56-9063-47C0-AEB7-1D315790C9D8Q30574663-FBBC955A-26FE-44C2-9E50-8352ED1F4C95Q35162006-FE39EC6B-4481-47FE-BCD2-503A4B245E6EQ35558056-D70FAB92-829F-43C8-87FE-340E4A72726FQ35724421-A9699BD3-F2A9-4C2D-837A-FA87FAF8E283Q35818371-0521AA01-A62F-4EC4-A855-67D780FF4DFDQ37573646-F159CB61-325E-4992-AFE1-7A61608E5376Q38178061-7CA5D018-887B-49C0-A660-9D6BF89E6B5BQ38557791-D42AF35D-7C4A-460D-9BC7-E2B396905AC6Q38603658-F4A6F95A-89AB-4A1E-92FA-3DF7D99186B8Q38786687-B14B0FED-109F-4CBF-99B1-57F377976C26Q39368114-BCC31EB2-7829-43C0-A46D-4986C0FE9699Q46585617-A90C2667-1360-4BAE-BF79-FBC90C86F1D3Q47103310-1D966BA4-CF79-446E-A313-076562A9CAC8Q51480634-0DDB2F29-6E36-4B11-8A8D-36DEA16C3C0EQ58716650-F2B15F19-113A-4F35-A1C4-2069C4BFEF27
P2860
Exon skipping and gene transfer restore dystrophin expression in human induced pluripotent stem cells-cardiomyocytes harboring DMD mutations.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Exon skipping and gene transfe ...... cytes harboring DMD mutations.
@en
Exon skipping and gene transfe ...... cytes harboring DMD mutations.
@nl
type
label
Exon skipping and gene transfe ...... cytes harboring DMD mutations.
@en
Exon skipping and gene transfe ...... cytes harboring DMD mutations.
@nl
prefLabel
Exon skipping and gene transfe ...... cytes harboring DMD mutations.
@en
Exon skipping and gene transfe ...... cytes harboring DMD mutations.
@nl
P2093
P2860
P356
P1476
Exon skipping and gene transfe ...... cytes harboring DMD mutations.
@en
P2093
Annemieke Aartsma-Rus
David Anderson
Emily Dick
Morten Ritso
Rita Barresi
Spandan Kalra
Steven H Laval
Vinoj George
P2860
P304
P356
10.1089/SCD.2013.0135
P577
2013-07-05T00:00:00Z